Induction of Anergy in Th1 Cells Associated with Increased Levels of Cyclin-Dependent Kinase Inhibitors p21Cip1 and p27Kip1 1
- 15 January 2001
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 166 (2) , 952-958
- https://doi.org/10.4049/jimmunol.166.2.952
Abstract
Th1 cells exposed to Ag and the G1 blocker n-butyrate in primary cultures lose their ability to proliferate in Ag-stimulated secondary cultures. The ability of n-butyrate to induce anergy in Ag-stimulated, but not resting, Th1 cells was shown here to be blocked by cycloheximide. Subsequent experiments to delineate the nature of the protein apparently required for n-butyrate-induced Th1 cell anergy focused on the role of cyclin-dependent kinase (cdk) inhibitors p21Cip1 and p27Kip1. Normally, entry into S phase by Th1 cells occurs around 24 h after Ag stimulation and corresponds with relatively low levels of both p21Cip1 and p27Kip1. However, unlike control Th1 cells, anergic Th1 cells contained high levels of both p21Cip1 and p27Kip1 when examined 24 h after Ag stimulation. The increase in p21Cip1 observed in Ag-stimulated anergic Th1 cells appeared to be initiated in primary cultures. In contrast, the increase in p27Kip1 observed in these anergic Th1 cells appears to represent a re-expression of the protein much earlier than control cells following Ag stimulation in secondary cultures. The anergic Th1 cells contained functionally active cdk inhibitors capable of inhibiting the activity of both endogenous and exogenous cdks. Consequently, it appears that n-butyrate-induced anergy in Th1 cells correlated with the up-regulation of p21Cip1 and perhaps the downstream failure to maintain low levels of p27Kip1. Increased levels of both p21Cip1 and p27Kip1 at the end of G1 could prevent cdk-mediated entry into S phase, and thus help maintain the proliferative unresponsiveness found in the anergic Th1 cells.Keywords
This publication has 25 references indexed in Scilit:
- Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cellsOncogene, 1999
- p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilizationBiochemical Journal, 1999
- Butyrate Stimulates Cyclin D and p21 and Inhibits Cyclin-Dependent Kinase 2 Expression in HT-29 Colonic Epithelial CellsBiochemical and Biophysical Research Communications, 1997
- Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways.The Journal of Experimental Medicine, 1996
- Blocked Signal Transduction to the ERK and JNK Protein Kinases in Anergic CD4 + T CellsScience, 1996
- Induction of G1 arrest by down-regulation of cyclin D3 in T cell hybridomas.The Journal of Experimental Medicine, 1995
- A cell cycle-regulated inhibitor of cyclin-dependent kinases.Proceedings of the National Academy of Sciences, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- Transactivation by AP-1 Is a Molecular Target of T Cell Clonal AnergyScience, 1992
- Differential induction of transcription factors that regulate the interleukin 2 gene during anergy induction and restimulation.The Journal of Experimental Medicine, 1992